Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
At Hospital/Institution:  Presbyterian - St. Luke's Medical Center, Presbyterian - St. Luke's Medical Center
Keywords/Phrases:  gastrointestinal cancer
Results 1-25 of 4208 for your search:
Start Over
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Ropidoxuridine in Treating Patients with Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BrUOG 265, NCI-2015-00258, 9882, NCT02381561
Ganetespib and Ziv-Aflibercept in Treating Patients with Refractory or Metastatic Gastrointestinal Cancer, Non-small Cell Lung Cancer, Urothelial Cancer, or Sarcoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: 14-C-0150, NCI-2014-00626, 141525, 9605, NCT02192541
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI608-246, NCI-2015-00892, NCT02024607
A Phase 2 Study of Fosbretabulin in Subjects With Gastrointestinal Neuroendocrine Tumors With Elevated Biomarkers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OX4218s, NCI-2014-02047, NCT02132468
Proton Beam Radiation Therapy and Fluorouracil or Capecitabine in Treating Patients With Upper Gastrointestinal Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 09211, NCI-2011-03312, NCT01449864
Mutation-Targeted Therapy with Sunitinib Malate or Everolimus in Treating Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal Tract or Pancreas
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 15-C-0040, NCI-2015-00091, 14-C-0000, 150040, 339636, P141605, NCT02315625
Alisertib and Combination Chemotherapy in Treating Patients with Gastrointestinal Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC PHIXXXX, NCI-2014-02475, 9824, NCT02319018
Sorafenib Tosylate and Capecitabine in Treating Patients With Advanced Breast or Gastrointestinal Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: HIC # 1112009424, NCI-2013-00893, 1112009424, ONC-2010-35, NCT01640665
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: OX4219s, NCI-2015-00120, NCT02279602
Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: SNX5422-CLN-009, NCI-2014-02577, NCT02063958
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 18 and over
Trial IDs: CGI-061, NCI-2013-01950, NCT02092714
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: AAA-III-01, NCI-2012-02037, 2011-005049-11, NCT01578239
Pazopanib Hydrochloride in Treating Patients with Progressive Carcinoid Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A021202, NCI-2013-00831, ALLIANCE A021202, CALGB-A021202, NCT01841736
Early Palliative Care or Standard Care in Improving Quality of Life in Patients with Metastatic Lung or Non-Colorectal Gastrointestinal Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 10-434, NCI-2011-00961, NCT01401907
Domperidone in Treating Patients with Gastrointestinal Disorders
Phase: Phase III
Type: Treatment
Age: 16 and over
Trial IDs: 2012-0261, NCI-2012-02093, NCT01696734
Surgery or Non-surgical Management in Treating Patients with Intra-abdominal Cancer and Bowel Obstruction
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: S1316, NCI-2014-01497, SWOG-S1316, NCT02270450
Pasireotide in Reducing Gastrointestinal Toxicity from Chemotherapy and Radiation in Patients Undergoing a Donor Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00051736, NCI-2014-02316, NCT02215070
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: BBI503-205GYN-M, NCI-2015-01020, NCT02432690
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: HS410-101, NCI-2014-01420, NCT02010203
A Study of BBI608 in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-101, NCI-2012-02181, NCT01775423
Educational Intervention in Changing Patient-Reported Constipation Perception in Patients with Advanced Cancer
Phase: No phase specified
Type: Educational/Counseling/Training
Age: 18 and over
Trial IDs: 2015-0111, NCI-2015-00734, NCT02422329
Trametinib in Treating Patients with Advanced Cancer with or without Hepatic Dysfunction
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PJC-015, NCI-2014-00416, 9591/PJC-015, NCI 9591, NCT02007382, 9591, NCT02070549
Autologous Fecal Microbiota Transplant in Preventing Clostridium Difficile Infection in Patients with Cancer Undergoing Donor Hematopoietic Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 14-025, NCI-2014-02206, NCT02269150
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Phase: Phase II, Phase I
Type: Supportive care
Age: Not specified
Trial IDs: SAL 2012-0584, NCI-2014-00167, NCT01739634
Start Over